PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.\', \'Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-sen University, Guangzhou, China.\', \'Shenzhen Center for Disease Control and Prevention, Shenzhen, China.\', \'Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China.\', \'Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.\', \'Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.\', \'Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.632814
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33763078
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all